Restarting Thalidomide-Dexamethasone Regimen in a Post-Abortive Female with Multiple Myeloma: Effective Clinical Response Possible
Nowadays, the prevalence of Multiple Myeloma (MM) seems to have been increasing among young females. Here, we report that thalidomide is contraindicated in pregnant women diagnosed with MM and those desirous of subsequent pregnancy. In this case report, we compared the clinical response of Thalidom...
Main Authors: | Suhailur Rehman, S. H. Arif, Amit Kumar, A. Q. Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2017-07-01
|
Series: | International Journal of Hematology-Oncology and Stem Cell Research |
Subjects: | |
Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/840 |
Similar Items
-
Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma
by: Taleb Azarm, et al.
Published: (2012-01-01) -
Effects of bortezomib combined with dexamethasone and thalidomide on bone metabolism regulating factors, immune function and renal function in patients with multiple myeloma complicated with renal insufficiency
by: Rong Hu, et al.
Published: (2017-11-01) -
Thalidomide-based Regimens for Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-analysis
by: Wen-Wen Lyu, et al.
Published: (2016-01-01) -
Thalidomide and its analogues in the treatment of Multiple Myeloma
by: Latif Tahir, et al.
Published: (2012-09-01) -
Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients
by: Priscilla Cury de Camargo Cury, et al.
Published: (2020-04-01)